Zeigler D W, Johnson J A, Koivunen D G, Siripaisarnpipat S, Fowler W L, Dostal D E, Payne C G
Am J Physiol. 1986 Jul;251(1 Pt 2):H196-204. doi: 10.1152/ajpheart.1986.251.1.H196.
This study consisted of five different experiments with conscious rabbits. In experiment 1, the angiotensin II (ANG II) antagonist [Sar1-Ala8]ANG II infused iv into one-kidney rabbits with renal artery stenosis (RAS) of 3 days' duration, at a dose that blocked pressor responses to ANG II, did not decrease the exaggerated pressor responses to norepinephrine (NE). In experiment 2, captopril infused iv into one-kidney, 3-day, RAS rabbits blocked pressor hyperresponsiveness to NE, and the concurrent infusion of [Sar1-Ala8]ANG II did not reestablish pressor hyperresponsiveness, indicating that this ANG II analogue had no agonistic action to promote hyperresponsiveness to NE. In experiment 3, infusion of ANG II at a subpressor dose (6.7 pmol . min-1 . kg body wt-1) into normal rabbits resulted in pressor hyperresponsiveness to NE, which was blocked by [Sar1-Ala8]ANG II. Experiment 4 involved infusing [Sar1-Ala8]ANG II or [Sar1-Ile8]ANG II at various doses into 3-day RAS rabbits, to determine their abilities to attenuate the pressor responses to ANG II (100 ng/kg) and the pressor hyper-responses to NE (800 ng . min-1 . kg-1). [Sar1-Ile8]ANG II decreased the ANG II pressor responses at an ID50 dose of 64 +/- 5 (SEM) pmol . min-1 . kg-1 and attenuated the NE pressor hyper-response at an ID50 dose of 65 +/- 5 pmol . min-1 . kg-1; [Sar1-Ala8]ANG II diminished the ANG II pressor response at an ID50 dose of 757 +/- 247 and the NE pressor hyper-response at an ID50 dose of 10,061 +/- 944 pmol . min-1 . kg-1.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究包括对清醒家兔进行的五项不同实验。在实验1中,将血管紧张素II(ANG II)拮抗剂[Sar1-Ala8]ANG II以能阻断对ANG II升压反应的剂量静脉注射到肾动脉狭窄(RAS)3天的单肾家兔体内,该剂量并未降低对去甲肾上腺素(NE)的过度升压反应。在实验2中,将卡托普利静脉注射到单肾、RAS 3天的家兔体内,可阻断对NE的升压高反应,同时注射[Sar1-Ala8]ANG II并不能恢复升压高反应,这表明该ANG II类似物没有促进对NE高反应的激动作用。在实验3中,以低于升压剂量(6.7 pmol·min-1·kg体重-1)向正常家兔注射ANG II,导致对NE的升压高反应,该反应被[Sar1-Ala8]ANG II阻断。实验4涉及向3天RAS家兔注射不同剂量的[Sar1-Ala8]ANG II或[Sar1-Ile8]ANG II,以确定它们减弱对ANG II(100 ng/kg)升压反应以及对NE(800 ng·min-1·kg-1)升压高反应的能力。[Sar1-Ile8]ANG II在ID50剂量为64±5(SEM)pmol·min-1·kg-1时可降低ANG II升压反应,在ID50剂量为65±5 pmol·min-1·kg-1时可减弱NE升压高反应;[Sar1-Ala8]ANG II在ID50剂量为757±247时可减弱ANG II升压反应,在ID50剂量为10,061±944 pmol·min-1·kg-1时可减弱NE升压高反应。(摘要截选至250词)